Mark D. Long
- Molecular Biology top 10%
- Oncology top 10%
- Cancer Research top 5%
- Immunology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Co-authors
- Moray J. CampbellDominic J. SmiragliaSong LiuSpencer R. RosarioHayley C. AffrontiAryn M. RowsamKevin H. EngDonald Küfe
- Topics
- Epigenetics and DNA Methylation (15 papers)RNA modifications and cancer (14 papers)Immunotherapy and Immune Responses (12 papers)
- Cited by
- Cancer ResearchOncologyImmunology
- Partner nations
- United StatesJapanChina
In The Last Decade
Mark D. Long
62 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 108
- Molecular Biology 778
- Oncology 423
- Cancer Research 358
- Immunology 288
- Pulmonary and Respiratory Medicine 254
Countries citing papers authored by Mark D. Long
This map shows the geographic impact of Mark D. Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. Long more than expected).
Fields of papers citing papers by Mark D. Long
This network shows the impact of papers produced by Mark D. Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. Long. The network helps show where Mark D. Long may publish in the future.
Co-authorship network of co-authors of Mark D. Long
This figure shows the co-authorship network connecting the top 25 collaborators of Mark D. Long. A scholar is included among the top collaborators of Mark D. Long based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark D. Long. Mark D. Long is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 3 | |
| 6 | 3 | |
| 7 | 16 | |
| 8 | 4 | |
| 9 | 2 | |
| 10 | 3 | |
| 11 | 13 | |
| 12 | 12 | |
| 13 | 8 | |
| 14 | 0 | |
| 15 | 25 | |
| 16 | 32 | |
| 17 | 7 | |
| 18 | 62 | |
| 19 | 46 | |
| 20 | 47 |
About Mark D. Long
Mark D. Long is a scholar working on Immunology, Oncology and Cancer Research, having authored 70 papers that have together received 1.4k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (15 papers), RNA modifications and cancer (14 papers) and Immunotherapy and Immune Responses (12 papers). The work is most often cited by research in Cancer Research (358 citations), Oncology (423 citations) and Immunology (288 citations). Mark D. Long has collaborated with scholars based in United States, Japan and China. Frequent co-authors include Moray J. Campbell, Dominic J. Smiraglia, Song Liu, Spencer R. Rosario, Hayley C. Affronti, Aryn M. Rowsam, Kevin H. Eng, Donald Küfe, Atsushi Fushimi and Nami Yamashita. Their work appears in journals such as Nucleic Acids Research, Journal of Clinical Investigation and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.